Semarion
PrivateLast Round
VC Round
Mar 31, 2026
Total Funding Raised
$3.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Semarion operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a VC Round in March 2026.
Semarion is a life sciences company that has developed the SemaCyte® platform, a microcarrier technology using materials engineering to accelerate adherent cell screening for drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Semarion Comparables
Compare Semarion with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CytoTronics | 81% | |
| CN Bio | 71% | |
| Emulate | 70% |
For institutional investors. Book with your work email.
Semarion Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 31, 2026 | ||||
| VC Round | Mar 17, 2025 | ||||
| Seed | Feb 22, 2022 | ||||
| Pre Seed | Jun 22, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Semarion Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Found Capital | VC Round |
| Start Codon | VC Round, Pre Seed |
| Cambridge Capital Group | VC Round |
| Cambridge Enterprise | VC Round |
| The FSE Group | VC Round |
| Found Capital | VC Round |
| Parkwalk Advisors | VC Round, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 102% MoM, reaching 798.
- Mar 31, 2026
$3.8M raised in Seed round.
For institutional investors. Book with your work email.
Semarion Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Semarion's valuation, stock price, and market status.
Is Semarion a public or private company?
Semarion is a private company.
What is the current stock price of Semarion?
Semarion is a private company, so its shares have no public market price. Caplight tracks Semarion's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Semarion worth (valuation)?
Valuation information for Semarion is not publicly available.
Can I buy Semarion stock?
Semarion shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Semarion's last funding round?
Semarion's most recent funding round was VC Round on March 31, 2026.
Who are the main investors in Semarion?
Key investors in Semarion include Start Codon, Parkwalk Advisors.
Will Semarion IPO soon?
No public IPO plans have been announced for Semarion.
How can I track Semarion secondary market activity?
Caplight tracks bids, offers, and trades in Semarion's shares on secondary markets.